Legal Notice

INFORMATION SOCIETY SERVICES AND E-COMMERCE (LSSICE, in Spanish):
Pursuant to the provisions of Article 10 of the Information Society Services and Electronic Commerce (LSSICE) Act 34/2002 of July 11, 2002, VIVUNT PHARMA S.L.
makes available the following identification data to the users of this website:
WEBSITE OWNER: VIVUNT PHARMA S.L. CIF: B02655470
Address: C/ Luis Carmona, 5. León. Email: rgpd@vivunt.es
Activity: Pharmaceuticals Manufacturer.
Commercial Register Record: R.M. León, Volume 1355, File 213, Page LE-26743 (first inscription). Administrative Authorization: in process.

• WEBSITE CONDITIONS OF ACCESS AND USE
This legal notice regulates the use of the www.vivunt.es website, which is owned by VIVUNT PHARMA S.L. and is made available to web users in order to comply
with the stipulations under the Information Society Services and Electronic Commerce (LSSICE) Act 34/2002 of July 11, 2002, as well as to inform about the
conditions of use of said website.
Website access is free of charge, except for the cost of the connection through the telecommunications network provider hired by users. Any person accessing this
website assumes the role of user, committing to the observance and strict compliance of the provisions herein, as well as any other legal provision that may be
applicable. VIVUNT PHARMA S.L. reserves the right to modify any type of information that may appear on the website, without any obligation to give prior notice or
inform users of such obligations, with publication on this site being understood as sufficient.
Our company guarantees the security and confidentiality in all communications with our web users through a secure server, based on the SSL standard that protects
data against attempts of violation by any third parties.

• COMMERCIAL COMMUNICATIONS
If the web user has subscribed to our newsletter or has given their consent to receiving advertising or commercial communications, we inform that, under the
Information Society Services and Electronic Commerce (LSSICE) Act 34/2002 of July 11, 2002, they might be able to revoke their consent by sending a
communication to our company via email rgpd@vivunt.es.

• INTELLECTUAL PROPERTY.
All the contents that appear on the VIVUNT PHARMA S.L. website and particularly designs, texts, logos, images, trademarks, icons and other signs that appear on the
VIVUNT PHARMA S.L. website are the exclusive property of the company and/or its collaborators, and are subject to the corresponding Intellectual Property rights.
The user may not reproduce, communicate, copy, distribute, transform or modify the contents of the website, unless expressly authorized by VIVUNT PHARMA S.L.
VIVUNT PHARMA S.L. reserves the right to modify, delete or restrict web content, links or information without prior notice.
It is forbidden to manipulate and/or suppress the "copyright" as well as technical protection devices, or any information mechanism contained in the website.
Additionally, illicit messages or contents may not be sent or transmitted through the website.
VIVUNT PHARMA S.L. reserves the right to modify, delete or restrict any web content, links or information without prior notice.
VIVUNT PHARMA S.L. reserves the right to modify, delete or restrict any web content, links or information without prior notice.
The user must be committed to respect the aforementioned rights and to avoid any action that could result in any harm. VIVUNT PHARMA S.L. reserves the right to
take the corresponding legal actions to protect its legitimate intellectual and industrial property rights.

• Links
The VIVUNT PHARMA S.L. website may include links that allow the user to access Internet pages managed by third parties and are external to the company. VIVUNT
PHARMA S.L. is not responsible for the contents, information or services detailed in these pages, since these links are intended only for informative purposes.
Accordingly, it shall not be liable for damages that may result from access to the linked pages.
The user is authorized to create links from the website, provided that they are not reproduced on webpages that contain illegal, offensive or discriminatory
materials. In addition, the information in hyperlinks may not be falsified or modified; therefore, it is not allowed to include distinctive signs, trade names,
trademarks, logos or denominations of the company, with the exception of those that are already part of said denominations.
VIVUNT PHARMA S.L. may request, at any time, the removal of any links to the website; after which they shall be deleted immediately.

• Disclaimer
VIVUNT PHARMA S.L. is not responsible for any damage that the website may cause to the user's computer system as a result of security errors due to the use of
malicious programs, malfunctioning of the browser, use of outdated versions and/or improper use of the website. The continuous operation of the electronic
system is not guaranteed, nor the correct visualization of contents or downloads. Likewise, it does not provide a guarantee against the existence of errors and/or
outdated content gathered in the website, although efforts will be directed to resolve those failures.

• DATA PROTECTION POLICY YOU MAY CHECK IT HERE
COOKIES POLICY YOU MAY CHECK IT HERE
APPLICABLE LEGISLATION AND JURISDICTION

For the resolution of all disputes or questions related to this website or the activities carried out therein, the Spanish law shall apply, to which the parties expressly submit themselves, and the Courts and Tribunals of LEÓN (SPAIN) shall be competent for the resolution of all disputes arising from or related to its use.

list of immuno oncology drugs, immuno oncology drugs, care oncology clinic drugs, care oncology drugs, common oncology drugs, drugs used in oncology, immuno oncology drugs list, msd oncology drugs, oncologic drugs advisory committee, oncology drugs, oncology drugs list, oncology drugs market, oncology drugs market size, oncology nursing drug handbook, oncology pipeline drugs, repurposing drugs in oncology, top oncology drugs, top selling oncology drugs, what are oncology drugs, approved immuno oncology drugs, biosimilar oncology drugs, bms immuno oncology drugs, cost of oncology drugs, drug information handbook for oncology, fda approved immuno oncology drugs, fda approved oncology drugs, generic oncology drugs, immuno oncology drug discovery, immuno oncology drugs in development, most expensive oncology drugs, new oncology drugs, oncology chemotherapy drugs, oncology drug classes, oncology drug companies, oncology drug development, oncology drug discovery, oncology drug interactions, oncology drug trails cro oncology drugs advisory committee oncology drugs classification oncology drugs list pdf oncology drugs names

Would you like to be
part of VIVUNT?

Attach your CV


Contact our team